2021 Annual Meeting | Industry Therapeutic Update from Novartis Pharmaceuticals Corporation: KESIMPTA® (ofatumumab) for Relapsing MS: Powerful Efficacy, Targeted Therapy, and Flexible Self-Administration

Date Saturday 04/17/21

Time 01:00 PM - 02:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Topic(s)

CME Available No CME available

Event Timeline
No timeline events available at this time.